US EPA moves to approve dicamba weedkiller use on cotton, soybeans

The US EPA has proposed new approvals for three dicamba weedkiller products, arguing they pose no significant human health or environmental risk, despite a 2024 federal court ruling that previously halted their use due to procedural violations and concerns over drift damage to neighboring plants. This move, following applications from Bayer, BASF, and Syngenta, aims to re-enable farmers to use the herbicide on genetically engineered cotton and soybean crops, with the EPA proposing application restrictions to mitigate plant risks. The re-approval would restore a critical tool for farmers, addressing a gap left by the prior ban.

Analysis

The U.S. Environmental Protection Agency's (EPA) proposal to re-approve three dicamba-based herbicides is a material positive development for the product's manufacturers, notably Bayer AG (BAYRY) and BASF (BASFY). This regulatory action seeks to reverse a 2024 federal court ruling that had vacated previous registrations due to procedural issues and environmental concerns, specifically the herbicide's tendency to drift and damage non-target plants. The EPA's current position, based on a new review, is that the products pose no significant human health risk, and that risks to plants can be mitigated via proposed restrictions on application timing and quantity. For Bayer and BASF, this signals the potential reopening of a market for a product described by the American Soybean Association as a "critical tool," addressing a commercial void left by this year's sales ban. However, the proposal is not final and remains subject to a public comment period and the persistent threat of litigation from environmental groups that have successfully challenged approvals in the past. The mentioned potential conflict of interest involving a senior EPA official could also become a focal point for opposition, introducing a degree of regulatory and legal uncertainty.

Key Decisions for Investors

• Investors with positions in Bayer (BAYRY) and BASF (BASFY) should view the EPA's proposal as a significant positive catalyst that could restore a key revenue stream to their respective crop science divisions.
• It is critical to monitor the public comment period and for any signs of renewed legal challenges from environmental groups, as successful litigation represents the primary risk that could derail the re-approval process.
• The final terms of the approval, particularly the specific restrictions on use, should be closely evaluated as they could materially impact the product's market adoption and competitive positioning against alternatives.